Home/Filings/4/0001415889-24-019676
4//SEC Filing

RENTON HOLLINGS 4

Accession 0001415889-24-019676

CIK 0001370053other

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 4:45 PM ET

Size

11.3 KB

Accession

0001415889-24-019676

Insider Transaction Report

Form 4
Period: 2024-07-15
Transactions
  • Exercise/Conversion

    Common Stock

    2024-07-1510,00030,925 total
    Exercise: $6.93Exp: 2025-07-05Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-07-15$6.93/sh+10,000$69,30011,950 total
  • Sale

    Common Stock

    2024-07-15$30.50/sh7,103$216,6684,847 total
  • Sale

    Common Stock

    2024-07-15$30.98/sh2,897$89,7541,950 total
Footnotes (4)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.91 to $30.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.92 to $31.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001187333

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:45 PM ET
Size
11.3 KB